|
Originally published In Press as doi:10.1074/jbc.M805611200 on July 28, 2008
J. Biol. Chem., Vol. 283, Issue 39, 26538-26547, September 26, 2008
Parallel Phosphatidylinositol 3-Kinase (PI3K)-dependent and Src-dependent Pathways Lead to CXCL8-mediated Rac2 Activation and Chemotaxis*
Jiqing Sai ,
Dayanidhi Raman ,
Yuxin Liu ,
John Wikswo , and
Ann Richmond ¶1
From the
¶Department of Veterans Affairs and Department of Cancer Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232 and the VIIBRE and Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, Tennessee 37212
The requirement for phosphatidylinositol 3-kinase (PI3K) in the establishment of cell polarity and motility in a number of cell types has recently come into question. In this study, we demonstrate that inhibition of PI3K by wortmannin in neutrophil-like differentiated HL60 cells expressing CXCR2 resulted in reduced cell motility but normal chemotaxis in response to a gradient of CXCL8. However, wortmannin inhibition of PI3K did impair the ability of cells to re-orient their polarity and respond quickly to a change in the direction of the CXCL8 gradient. We hypothesized that Src-regulated ELMO-Dock2-Rac2 activation mediates chemotaxis in the absence of PI3K activity. Inhibition of Src with the small molecule inhibitor, PP2, or inhibition of Dock2 by shRNA knockdown confirmed the functional role of Src and Dock2 in regulating chemotaxis when PI3K was inhibited. Moreover, neutrophils isolated from bone marrow of hck-/-fgr-/-lyn-/- mice exhibited much more severe inhibition of chemotaxis when PI3K was blocked with wortmannin as compared with neutrophils isolated from bone marrow of wild-type mice. Thus, PI3K and Src-ELMO-Dock2 pathways work in parallel to activate Rac2 and modulate chemotaxis in response to a CXCL8 gradient in neutrophils.
Received for publication, July 22, 2008
* This work was supported, in whole or in part by National Institutes of Health Grants CA34590 (to A. R.) and NCI U54CA113007 (to Vito Quaranta). This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs (to A. R.), the Vanderbilt Institute for Integrative Biosystems Research and Education and the Vanderbilt Academic Venture Capital Fund (to J. W.), and the Vanderbilt Ingram-Cancer Center Grant CA68485 (to Jennifer Pietenpol). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Movies S1–S4, Tables S1 and S2, and Figs. S1–S3.
1 To whom correspondence should be addressed: Dept. of Cancer Biology, School of Medicine, Vanderbilt University, Nashville, TN 37232. Tel.: 615-343-7777; Fax: 615-936-2911; E-mail: ann.richmond{at}vanderbilt.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. F. Neel, M. Barzik, D. Raman, T. Sobolik-Delmaire, J. Sai, A. J. Ham, R. L. Mernaugh, F. B. Gertler, and A. Richmond
VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis
J. Cell Sci.,
June 1, 2009;
122(11):
1882 - 1894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cataisson, R. Ohman, G. Patel, A. Pearson, M. Tsien, S. Jay, L. Wright, H. Hennings, and S. H. Yuspa
Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis
Cancer Res.,
January 1, 2009;
69(1):
319 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|